COVID-19 mRNA Vaccine-Associated Myocarditis Presenting as STEMI in a 48-Year-Old Male. (15th April 2022)

• Record Type: Journal Article
• Authors: Dlewati, Mohammad; Park, Kyeeun; Rawat, Saumya; Conte, Jorge; Bhadha, Kashmira
• Other Names: Shirotani Manabu Academic Editor.
• Is Part Of: Case reports in cardiology. Volume 2022(2022)
• Publication Date: 2022-04-15
• Subjects: Cardiology -- Periodicals; 616.12005
• DOI: 10.1155/2022/2284530
• Languages: English
• ISSNs: 2090-6404

Abstract

Abstract : Myocarditis has been recognized as a rare complication of coronavirus disease 2019 (COVID-19) mRNA vaccinations. Young adult and adolescent males < 30 years of age are the most commonly affected group, with decreased incidence with older age. This is a case of a 48-year-old male who presented with chest pain and EKG findings of STEMI shortly after receiving the second dose of the Moderna COVID-19 mRNA vaccine. Emergent left heart catheterization revealed normal coronaries. Subsequently, the patient had rapid resolution of his symptoms and improvement in serum markers. The exact etiology factors to this new and rare phenomenon are yet to be fully understood. This patient did have a history of previous viral myocarditis 7 years ago; however, it remains unclear if this could be a predisposing factor to the development of mRNA vaccine-associated myocarditis.